Cargando…
Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology
SIMPLE SUMMARY: Cell-free DNA—DNA that has been expelled from cells and can be isolated from blood plasma and other body fluids—is a useful tool in medicine, with applications as a biomarker in diagnosis, prognosis, disease profiling, and treatment selection. In oncology, the ease of access to the t...
Autores principales: | Werner, Bonnita, Warton, Kristina, Ford, Caroline E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909855/ https://www.ncbi.nlm.nih.gov/pubmed/35267615 http://dx.doi.org/10.3390/cancers14051309 |
Ejemplares similares
-
The untapped potential of ascites in ovarian cancer research and treatment
por: Ford, Caroline Elizabeth, et al.
Publicado: (2020) -
Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight
por: Werner, Bonnita, et al.
Publicado: (2019) -
Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
por: Muinelo-Romay, Laura, et al.
Publicado: (2018) -
Liquid biopsies in pediatric oncology: opportunities and obstacles
por: Sundby, R. Taylor, et al.
Publicado: (2022) -
Transcending the self to transcend suffering
por: Ge, Brian H., et al.
Publicado: (2023)